Scientists have identified a key molecule involved in the development of cerebral malaria, a deadly form of the tropical disease. The study identifies a potential drug target and way forward toward alleviating this condition for which few targeted treatments are available.
Malaria still infects millions of people every year and kills more than 400,000 — mostly children in Africa — because the fight against the mosquito-borne disease has stalled, the World Health Organization (WHO) said on Wednesday.
Eradicating malaria is biologically feasible and a lofty aim, the World Health Organization (WHO) said on Friday, but the focus for now should be getting the funds, tools and political will to control it.
Malaria has killed more than 1,800 people in Burundi this year, the United Nations (UN)’s humanitarian agency says, a death toll rivaling a deadly Ebola outbreak in the neighboring Democratic Republic of the Congo.
Research on a radical new way to combat malaria and other devastating diseases could be knocked off track if a UN biodiversity conference imposes a moratorium on the work, a group of scientists have said.
Study findings showed that standard molecular diagnostics detect most potentially transmissible malaria infections and cannot be replaced by rapid diagnostic testing to screen for potential Plasmodium falciparum transmitters, researchers reported in The Lancet Infectious Diseases.